TrialJournal of the American Society of Nephrology : JASN2021

A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.

Konstantin Doberer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.